Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/5/2026
Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
2/5/2026
China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...
2/5/2026
Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
2/4/2026
CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...
2/4/2026
Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...
2/4/2026
China's Health Insurance Market Poised for $596B Surge by 2033
2/4/2026
Almirall's Seysara Approved in China for Moderate-to-Severe Acne
2/4/2026
WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
2/4/2026
Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
2/4/2026
Vertex Takes Global Control of WuXi Biologics Trispecific T-Cell Engag...
2/4/2026
Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...
2/3/2026
China Tightens BMI Fund Oversight for 2026 With Nationwide Crackdown o...
2/3/2026
China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...
2/3/2026
Hengrui's Camrelizumab Combo Accepted by FDA for First-Line Liver Canc...
2/3/2026
New Indication for Novartis' Secukinumab in Non-Radiographic Axial Spo...
2/3/2026
HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...
2/3/2026
Beijing-Based PrimeGenX Therapeutics' HKSE IPO Application Accepted
1/31/2026
Recent Official and Executive Moves
1/30/2026
Formation Bio Licenses Oral miR-124 Activator FHND5032 from CTFH for A...
1/30/2026
CMS Secures NMPA Approval for Opzelura in Non-Segmental Vitiligo
1/30/2026
Roche's 2025 Results Highlight Strong China Growth amid Global Expansi...
1/30/2026
China's Basic Medical Insurance Fund Posts Solid Surplus in 2025 as In...
1/29/2026
AstraZeneca Deepens China Commitment With $15B Investment
1/29/2026
Phase III Trial Shows Anbenitamab Significantly Improves Survival in H...
1/28/2026
China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
1/27/2026
Boehringer Ingelheim Strikes €1.05B Deal With Simcere for Preclinical...
1/27/2026
NMPA Adopts ICH M14 Guideline on Real-World Evidence for Drug Safety E...
1/27/2026
China's Early-Stage Drug Advantage Seen Persisting: Pitchbook
1/27/2026
China's Labs Pull Ahead as Global Drugmakers Invest in Biotech Pioneer...
1/26/2026
Huahui Wins Conditional Approval in China for First Hepatitis D Therap...
Page:
5
/
382
Total number of articles:
11455
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit